Caricamento...

Biomarker development for myasthenia gravis

Biomarkers are defined as characteristics (proteins, RNA, single nucleotide polymorphisms, imaging) that are objectively measured and evaluated as an indicator of pathogenic processes or pharmacologic responses to a therapeutic intervention. Biomarkers are important in clinical trials where the robu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kaminski, Henry J., Kusner, Linda L., Wolfe, Gil I., Aban, Inmaculada, Minisman, Greg, Conwit, Robin, Cutter, Gary
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539232/
https://ncbi.nlm.nih.gov/pubmed/23278584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1749-6632.2012.06787.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !